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Non-secretor statusdue tohomozygosity for the commonFUT2variant c.461G>A (p.Trp154*) is associatedwith either risk for autoimmune
diseases or protection against viral diarrhea and HIV.We determined the role of FUT2 in otitis media susceptibility by obtaining DNA sam-
ples from609multi-ethnic families and simplex case subjects with otitismedia. Exome and Sanger sequencing, linkage analysis, and Fisher
exact and transmission disequilibrium tests (TDT) were performed. The common FUT2 c.604C>T (p.Arg202*) variant co-segregates with
otitis media in a Filipino pedigree (LOD¼ 4.0). Additionally, a rare variant, c.412C>T (p.Arg138Cys), is associated with recurrent/chronic
otitis media in European-American children (p¼ 1.23 105) andUS trios (TDT p¼ 0.01). The c.461G>A (p.Trp154*) variantwas also over-
transmitted in US trios (TDT p ¼ 0.01) and was associated with shifts in middle ear microbiota composition (PERMANOVA p < 107) and
increased biodiversity.When allmissense and nonsense variants identified inmulti-ethnic US trioswithCADD> 20were combined, FUT2
variantswereover-transmitted in trios (TDTp¼0.001).Fut2 is transientlyupregulated inmousemiddle ear after inoculationwithnon-type-
able Haemophilus influenzae. Four FUT2 variants—namely p.Ala104Val, p.Arg138Cys, p.Trp154*, and p.Arg202*—reduced A antigen in
mutant-transfected COS-7 cells, while the nonsense variants also reduced FUT2 protein levels. Common and rare FUT2 variants confer
susceptibility to otitis media, likely by modifying the middle ear microbiome through regulation of A antigen levels in epithelial cells.
Our families demonstratemarked intra-familial genetic heterogeneity, suggesting thatmultiple combinations of commonand rare variants
plus environmental factors influence the individual otitis media phenotype as a complex trait.Introduction
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FUT2 has been associated withmultiple phenotypes, either
(1) conferring risk for recurrent urinary tract infection,
infection with Neisseria meningitidis or Streptococcus pneu-
moniae, meningitis/sepsis/cellulitis due to Haemophilus in-
fluenzae, mucosal candidiasis, and autoimmune diseases,
or (2) protecting against specific viruses and Pseudomonas
sp. infection in cystic fibrosis (Table S1). These associations
were detected for a stop variant FUT2 c.461G>A
(p.Trp154*; rs601338) that has a minor allele frequency
(MAF) of 0.26–0.50 in multiple gnomAD populations
except East Asians (MAF ¼ 0.002). It was hypothesized
that positive selection for rs601338 occurred in non-East
Asian populations because the variant confers protection
against viral diarrhea1 (Table S1). In the GTEx Portal,
cis-eQTL analysis further supports a significant effect of
rs601338 on FUT2 expression in salivary gland, colon,
and lung; however, GTEx did not include the middle
ear. A genome-wide association study (GWAS) involving
>120,000 European-descent individuals identified a syn-
onymous FUT2 variant (rs681343) in strong linkage
disequilibrium (LD) with rs601338 as the most significant
locus for childhood ear infections,2,3 but the locus has not
been replicated and the estimated effect was small and pro-
tective (odds ratio/OR ¼ 0.9; p ¼ 3.5 3 1030). Addition-
ally, case status was based on adult anamnesis rather
than medical records and/or otologic examination.2,3
The goal of this study is to determine the role of FUT2 in
otitis media by sequencing DNA samples from families
and individuals with otitis media from various ethnicities,
by testing Fut2 expression or FUT2 localization in mouse
and humanmiddle ear and also expression in human saliva
from individuals with otitis media, and by determining
the effect of FUT2 variants on cellular FUT2 and A antigen
levels. Previously using exome data, we identified two rare
A2ML1 variants (duplication c.2478_2485dupGGCTAAAT
and splice variant c.4061þ1G>A) conferring otitis media
susceptibility in an intermarried, indigenous Filipino
population.4However, 22of 83 (26.5%) affected indigenous
individuals with DNA samples are wild-type for A2ML1 var-
iants. Here we report a population-specific FUT2 variant
c.604C>T (p.Arg202*) as a risk factor for otitismedia suscep-
tibility in indigenous Filipinos who are A2ML1-negative.
Moreover, we identified additional missense variants in
European-American and Pakistani families with recurrent
acute or chronic otitis media. We also show that the
c.461G>A (p.Trp154*) variant likewise confers otitis media
risk and induces shifts in the middle ear microbiome. Our
findings are further supported by increased Fut2 expression
in infected wild-type mouse middle ear and lower FUT2
and A antigen levels in cells transfected with FUT2 variants.Subjects and Methods
Ethics Approval
Prior to study onset, approval was obtained from the following
institutional review boards (IRB): Colorado Multiple IRB; Helsinki680 The American Journal of Human Genetics 103, 679–690, NovemUniversity Hospital; the National Commission on Indigenous Peo-
ples, Philippines; University of Maryland Baltimore; University of
Minnesota; University of the Philippines Manila (UPM); Univer-
sity of Texas Medical Branch (UTMB) Galveston; University of
Virginia; andUniversity ofWashington. Informed consent was ob-
tained from all adult participants and parents of children enrolled
in the study. In addition, approval was obtained from the Institu-
tional Animal Care and Use Committee of the Veterans Affairs
Medical Center, San Diego, California.Subject Ascertainment
An intermarried, indigenous Filipino population was reported to
have a high prevalence of otitis media due to A2ML1 variants.4 Ex-
panding on the previous study, a total of 137 individuals or 70% of
the population provided clinical data from multiple visits and
saliva samples for DNA isolation. The indigenous Filipinos diag-
nosed with otitis media are further described in Tables S2 and
S3. Middle ear swabs for microbiome study were also obtained
from 17 individuals with perforated eardrums due to chronic otitis
media then stored and shipped using Oragene P117 prototype
microbial kits (DNAgenotek). Microbial DNA isolation was per-
formed using the Epicenter MasterPure Kit. In addition, salivary
DNA samples were collected from 11 simplex case subjects from
the Philippine General Hospital (PGH) who underwent surgery
for chronic suppurative otitis media.
Otitis media-affected families from different cohorts were first
identified upon referral of a child or proband for otitis media sur-
gery (Table S2), except for the indigenous Filipino population. For
this study, 257 trios from Texas were enrolled. Clinical data
including age, sex, otitis media status and surgical technique,
and saliva samples were obtained from each individual (Table
S2). For Texas trios, both biological parents also provided saliva
samples. Additionally, 76 individuals from Colorado who under-
went surgery provided clinical data and saliva samples (Table
S2). All saliva samples were collected using Oragene DNA collec-
tion kits from which DNA was isolated using the manufacturer’s
protocol. For microbiome study, 13 Colorado individuals with
otitis media provided middle ear samples from which microbial
DNA was isolated using Epicentre kits.
DNA samples were also obtained from two previously estab-
lished family cohorts for otitis media, including 140 families
from the University of Minnesota5 and 105 families from Helsinki
University Hospital6 (Table S2). In Minnesota, all family members
were examined by an otolaryngologist and tested by tympanome-
try for middle ear function, and family members were considered
affected if R2 data sources, whether otoscopy, tympanometry,
medical records, or personal history, were positive for otitis media.
For Finnish families, clinical data, including history of otitis me-
dia, risk factors for otitis media, and otolaryngologic surgery,
were obtained. Finnish individuals were considered positive for
otitis media if they had insertion of tympanostomy tubes, effusive
otitis media for >2 months, or recurrent otitis media (i.e., >3 epi-
sodes in 6 months or >4 episodes in 12 months).
Nineteen families with otitis media were enrolled from the
southern Punjab province of Pakistan (Table S2). Age at onset
and recurrence of otitis media episodes were determined from
medical history and otitis media status by otoscopy. DNA was ex-
tracted from blood samples provided by family members who
participated in the study. For all cohorts, individuals with known
genetic, craniofacial, and immunodeficiency syndromes were
excluded.ber 1, 2018
Because Filipinos are not represented in any genomic database,
DNA samples were obtained from the Cebu Longitudinal Health
and Nutrition Survey (CLHNS) cohort7 in order to estimate variant
MAF in the general Filipino population. The CLHNS DNA samples
are from a prospective community-based birth cohort recruited
in 1983–1985 from Cebu, Philippines in order to study infant
feeding, socio-economic, and environmental factors that affect
health and nutrition outcomes, but not otitis media.7Human DNA Sequencing
Using DNA samples obtained from families and individuals with
otitis media, exome and Sanger sequencing were performed to
determine carriage of FUT2 variants. DNA samples from six indig-
enous Filipinos were submitted for exome sequencing at the
UWCMG, as previously described.4 Using an Illumina HiSeq in-
strument, exome sequencing was performed to an average depth
of 603. Sequence capture was performed using either the Roche
NimbleGen SeqCap EZ Human Exome Library v.2.0 or the Big
Exome 2011 Library. Burrows-Wheeler Aligner,8 Genome Analysis
Toolkit,9 and SeattleSeq were used to generate BAM, vcf, and anno-
tation files, respectively.
Sanger sequencing for FUT2 (GenBank: NM_000511.5) was per-
formed using DNA samples from the following: (1) the coding re-
gion in 257 Texan trios, 140 Minnesota probands and selected
Minnesota families, 105 Finnish probands, 76 Colorado probands,
and 19 Pakistani families; and (2) the c.604C>T (p.Arg202*;
rs1800028) variant in 137 indigenous Filipinos, 167 unrelated
CLHNS samples, and 11 individuals from the PGH who under-
went surgery for chronic otitis media.Bioinformatic, Linkage, and Statistical Analyses
In order to determine the predicted functional effect of identified
FUT2 variants, bioinformatic analyses were performed using
web tools available for the following software: fathmm,
MutationAssessor, MutationTaster, PolyPhen-2, and PROVEAN/
SIFT. Two-point affecteds-only analysis using Superlink10 was per-
formed using: (1) for Minnesota families, previously available ge-
notype data5 for the FUT2 c.772G>A (p.Gly258Ser; rs602662)
variant, while noting both LOD and HLOD scores; and (2) for
the indigenous Filipino pedigree, genotypes from Sanger
sequencing of rs1800028. For both analyses, otitis media was
assumed to be autosomal dominant with 90% penetrance and
1% phenocopy rate. All individuals with various otitis media types
were considered affected. For the rs602662 variant in Minnesota
families, nonparametric linkage analysis was also performed using
MERLIN.11
For variants identified in US and Finnish cohorts for which
gnomAD data are available, Fisher exact tests were performed
when comparing variant MAF by cohort versus population-
matched gnomADMAF. In Texas and Colorado trios, the transmis-
sion disequilibrium test (TDT) as described by Spielman et al.12
was performed for FUT2 variants. The TDT method is applicable
to themulti-ethnic Texas and Colorado cohorts because it is robust
against population stratification, allowing the inclusion of all 333
trios in TDT analysis.16S rRNA Sequencing and Microbiome Analysis
A total of 30 middle ear samples, 17 from indigenous Filipino and
13 fromColorado individuals with otitis media, were submitted for
16S rRNA sequencing and microbiome analysis. For 16S amplicon
library construction, bacterial profiles were determined by broad-The Americanrange amplification and sequence analysis of 16S rRNA genes
following previously described methods.13,14 In brief, amplicons
were generated using primers that target approximately 300 base
pairs of the V1-V2 variable region of the 16S rRNA gene. PCR prod-
ucts were normalized using a SequalPrep kit (Invitrogen/Thermo
Fisher Scientific), pooled, lyophilized, purified, and concentrated
using a DNA Clean and Concentrator Kit (Zymo). Pooled ampli-
cons DNA was diluted to 15 pM and spiked with 25% of the Illu-
mina PhiX control DNA prior to loading the sequencer. Illumina
paired-end sequencing was performed on the Miseq platform
with versions 2.4 of the Miseq Control Software and of MiSeq Re-
porter, using a 600 cycle version 3 reagent kit.
Illumina Miseq paired-end reads were aligned to human refer-
ence genome hg19 with Bowtie 215 and matching sequences dis-
carded. The remaining non-human paired-end sequences were
sorted by sample via barcodes in the paired reads with a Python
script.14 Paired reads were assembled using phrap.16,17 Pairs that
did not assemble were discarded. Assembled sequence ends were
trimmed over a moving window of 5 nucleotides until average
quality met or exceeded 20. Trimmed sequences with more than
1 ambiguity or shorter than 250 nt were discarded. Potential chi-
meras identified with UCHIME (usearch6.0.203_i86linux32)18 us-
ing the Schloss19 Silva reference sequences were removed from
subsequent analyses. Assembled sequences were aligned and clas-
sified with SINA (1.3.0-r23838)20 using the 418,497 bacterial se-
quences in Silva 115NR9921 as reference configured to yield the
Silva taxonomy. Operational taxonomic units (OTUs) were pro-
duced by clustering sequences with identical taxonomic assign-
ments. This process generated 1,193,018 sequences for 30 samples
(median of 28,066 sequences/sample; interquartile range: 6,785–
35,245 sequences/sample). Goods coverage scores were>96% for
all samples at the rarefaction point of 500 sequences, indicating
adequate depth of sequence coverage for all samples. Overall dif-
ferences in microbial community composition between groups
were assessed by PERMANOVA tests using Bray-Curtis dissimilarity
scores with 106–107 permutations. Differences in relative abun-
dances of individual OTUs were assessed by non-parametric Krus-
kal-Wallis tests. Standardmeasures of alpha biodiversity, including
richness (the number of OTUs per sample estimated by Chao1),
community evenness (the uniformity of OTU distributions esti-
mated by Shannon H/Hmax), and complexity (Shannon diversity),
were estimated at the rarefaction point of 500 sequences through
1,000 re-samplings; results were assessed by analysis of variance
tests. The software packages R and Explicet v2.10.822 were used
for data display, analysis, and figure generation.Expression of Fut2 mRNA in Mouse Middle Ear during
Acute Otitis Media
Information on Fut2 expression in the middle ear was derived
from microarray analysis of mRNA from wild-type mice that had
acute otitis media after inoculation with H. influenzae compared
to healthy control mice. Animals were 60- to 90-day-old wild-type
C57/WB F1 hybrid mice (Jackson). Non-typeable H. influenzae
(ntHI) strain 3655 (biotype II), originally isolated from the middle
ear of an individual with otitis media from St. Louis and provided
by Dr. AsaMelhus, LundUniversity, Sweden, was used at a concen-
tration of 105–106 bacteria/mL. Mice were anesthetized with ro-
dent cocktail (2.0 mg/kg xylazine and 40.0 mg/kg ketamine
i.m.). Both middle ear bullae were exposed in an aseptic surgery
by cervical midline incision. A small hole was made in each bulla
so as not to perforate the tympanic membrane. A 30 g needle wasJournal of Human Genetics 103, 679–690, November 1, 2018 681
then used to carefully inject 5 mL of inoculum into the middle ear.
The incision was closed and the tympanic membranes visually
confirmed to be intact. Animals were sacrificed at various intervals
after inoculation for tissue harvest. Uninoculated animals served
as controls.
Two groups of 20 C57BL/6:CB F1 hybrid mice per time point
were inoculated in the middle ear with ntHI strain 3655. Middle
ear tissues were harvested at 0 hr (control), 3 hr, 6 hr, 1 day,
2 days, 3 days, 5 days, and 7 days after inoculation to obtain
two independent biological replicates of the otitis media time
course. The tissue samples were homogenized in TRIzol (Invitro-
gen) and total RNA extracted. After confirmation of RNA quality,
mRNA was reverse transcribed using a T7-oligodT primer then
in vitro transcribed using T7 RNA polymerase to generate bio-
tinylated cRNA probes that were hybridized to Affymetrix
MU430 2.0 whole-genome microarrays. Raw hybridization inten-
sity data were median-normalized and statistical differences in
gene transcript expression levels were evaluated using variance-
modeled posterior inference (VAMPIRE).23 Bonferroni multiple
testing correction was applied. The expression of gene transcripts
encoding FUT2 was extracted from this dataset and normalized to
that in control (untreated) middle ears.Immunolocalization Studies
In order to test changes in cellular localization of FUT2 due to var-
iants, human FUT2 was amplified using human genomic DNA
and the PCR product was cloned into pEGFP-C2 vector. GFP-
FUT2Ala104Val, GFP-FUT2Arg138Cys, GFP-FUT2Trp154*, and GFP-
FUT2Arg202* constructs were generated using site-directed
mutagenesis protocol (Agilent). The following primary antibodies
were used: anti-FUT2 (Figure S1; 1:50e, NBP1-80775, Novus Bio-
logicals) and anti-Mannosidase II (1:200e, AB-12277, Abcam).
COS-7 and HEK293T cells were maintained in DMEM supple-
mented with 10% FBS, glutamine, and penicillin-streptomycin
(Invitrogen) at 37C, 5% CO2. Twenty-four hours before transfec-
tion, cells were plated on a coverslip. Cells were then transfected
with 2 mg of cDNA according to the Lipofectamine 2000 protocol
(Fisher Scientific). After 24 hr of transfection, cells were fixed with
4% PFA for 20 min, washed three times with PBS, permeabilized,
and blocked with 10% normal goat serum and 0.10% Triton
X-100 in PBS for 1 hr at room temperature. Cells were incubated
with primary antibodies overnight at 4C, washed three times
with PBS, and incubated with secondary antibodies for 1 hr at
room temperature. Cells were imaged using a Zeiss 710 confocal
microscope. Stacks of confocal images were acquired with a Z
step of 0.5 mm and processed using ImageJ software (NIH).
FUT2 localization was also determined in cholesteatoma tissue
from human middle ear. Paraffin sections of human cholestea-
toma were obtained from the Pathology Biorepository Shared Ser-
vices, University of Maryland School of Medicine. Sections were
deparaffinized using xylene and rehydrated gradually through
graded alcohols. Sections were heat-treated at 95C for 5 min in
a 10 mM sodium citrate buffer. Sections were then processed for
immunostaining.Flow Cytometry Studies
To examine the effect of FUT2 variants on cellular FUT2 and A
antigen levels, COS-7 cells were plated in a 10 cm dish and tran-
siently transfected with 10 mg of GFP-FUT2 variant constructs. Af-
ter 72 hr, cells were trypsinized and counted and 250K cells were
collected for each condition. Cells were immunostained overnight682 The American Journal of Human Genetics 103, 679–690, Novemwith IgM monoclonal blood Group A antigen antibody (Santa
Cruz; sc-69951) or IgM control antibody diluted in FACS buffer
(3% FBS PBS 1X). Cells were washed 3 times with FACS buffer
and incubated for 45 min with an APC conjugated anti-IgM sec-
ondary antibody. Cells were washed 3 times and processed for
flow cytometry analysis (BD LSR II).
Western Blot
In order to further determine FUT2 levels due to identified vari-
ants, COS-7 cells were plated in 100 mm culture dish for 24 hr
at 37C in 5% CO2. On the day of transfection, 10 mg of each
GFP-FUT2 variants were transfected into cells using Lipofectamine
2000. After 48 hr, cells were washed with cold 13 PBS, then ho-
mogenized with a sonicator (Fisher Scientific) at intensity setting
2 for 10 s in RIPA buffer containing a protease inhibitor mixture
(Roche/Sigma-Aldrich). Samples were diluted in 23 SDS sample
buffer. Samples were processed for western blot using 4%–20%
Tris Glycine gel (Novex, Thermo Fisher Scientific). Membranes
were probed with anti-GFP (Invitrogen, A-11122) and anti-
GAPDH (Santa Cruz, sc-32233) antibodies.
Human RNA-Sequencing and Network Analysis
RNA-sequencing and network analysis was also performed in order
to determine how FUT2 is related to other genes previously iden-
tified for otitis media. Using Oragene RNA kits, saliva was collected
from 23 individuals seen at the Children’s Hospital Colorado and
the University of Colorado Hospital who underwent surgery for
otitis media. Saliva was isolated according tomanufacturer’s proto-
col, achieving a median RIN of 7. RNA samples were submitted to
the University of Colorado Denver Genomics andMicroarray Core
for RNA-sequencing using the NuGen Trio RNA kit. An Illumina
HiSeq instrument was used for sequencing. The RNA-sequence
data were aligned to the human reference sequence (GRCh38)
using STAR.24 Summary counts were then generated using
featureCounts.25 Differential expression analysis using edgeR26
was implemented in NetworkAnalyst.27 The InnateDB data-
base28 was used to identify subnetworks of otitis-media-related
genes according to carriage of the FUT2 c.461G>A (p.Trp154*)
variant.Results
From the exome data of six indigenous individuals with
chronic otitis media, three were heterozygous and two ho-
mozygous for FUT2 c.604C>T (p.Arg202*; rs1800028),
which ClinVar classifies as pathogenic for plasma vitamin
B12 levels. Based on these exomes and Sanger sequencing
of an additional 131 samples, 54 indigenous individuals
were heterozygous and 6 homozygous for rs1800028
(MAF ¼ 0.24, Table S3). Of these 60 carriers of rs1800028, a
majority (58.3%) have current or previous diagnosis of otitis
media, including 15 out of 60 (25%) who carry rs1800028
but not an A2ML1 variant (Table S3). Sanger sequencing of
167 CLHNS DNA samples demonstrated that in the general
Filipinopopulation theMAFof rs1800028 is0.13, consistent
with previous reports in Southeast Asians.1,29 In gnomAD
the rs1800028 variant is most frequent in East Asians
(MAF ¼ 0.006) but is rarer in other populations (MAF %
0.0005) and was not detected in our non-Filipino cohorts.ber 1, 2018
AC
B
Figure 1. Indigenous Filipino (IPOM) Subpedigree and Microbiome Results for Middle Ear Samples from the IPOM and Colorado
Cohorts
(A) Indigenous Filipino subpedigree with the FUT2 c.604C>T (p.Arg202*; rs1800028) variant co-segregating with otitis media status, as
follows: IPOM112 (87 y.o.), cholesteatoma (red); IPOM8 (24 y.o.) and IPOM76 (9 y.o.), chronic otitis media (yellow); IPOM141 (5 y.o.),
effusive otitis media (orange); IPOM15 (12 y.o.), IPOM26 (50 y.o.), IPOM90 (47 y.o.), IPOM105 (36 y.o.), and IPOM156 (17 y.o.), healed
otitis media with healed perforations, sclerosis, and/or previously documented otitis media (gray); IPOM43 (25 y.o.), IPOM80 (32 y.o.),
and IPOM162 (40 y.o.), normal (clear with black border); unknown phenotype, clear with gray border. dup,A2ML1 duplication; wt,wild-
type.
(B) Average family-level relative abundances for individuals with otitis media from the indigenous Filipino community (IPOM) and Col-
orado (CU) defined by genotype for FUT2 stop variants. Nominally significant differences were identified in the Colorado cohort accord-
ing to genotype by permutation-based multiple analysis of variance (PERMANOVA) test (p < 107) using Bray-Curtis dissimilarities.
(C) Manhattan plot showing log10-transformed p values per bacterial family, ascertained by Kruskal-Wallis tests of wild-type versus
rs601338 (p.Trp154*) carriers within the Colorado cohort. Families with p < 0.1 are labeled on the plot and named to the right of
the plot.Linkage analysis for rs1800028 using the entire pedigree
connecting majority of ascertained individuals resulted in
LOD score deflation, even when A2ML1-variant-carriers
were specified as having unknown status. To resolve the
intra-familial genetic heterogeneity,30 a subpedigree con-
necting indigenous individuals who are wild-type for
A2ML1 variants but carried the FUT2 variant was recon-
structed (Figure 1A). Two-point linkage analysis resulted in
a statistically significant LOD score of 4.0 (q ¼ 0). However,
among 17 indigenous individuals with middle ear swabs,
we did not detect differences in the middle ear microbiome
due to carriage of the FUT2 c.604C>T (p.Arg202*) variant
(Figures 1B and 2).
When we Sanger-sequenced the FUT2 coding region in
257 trios from Texas, a rare missense variant FUT2
c.412C>T (p.Arg138Cys; rs1800022) that is not in LD
with c.461G>A (p.Trp154*) is heterozygous in 13 out ofThe American169 non-Hispanic European-American children who
had ventilation tube surgery (Table 1). This variant is pre-
dicted to be damaging by multiple bioinformatics tools
(fathmm, MutationAssessor, MutationTaster, PolyPhen-2,
PROVEAN, SIFT) and has overall gnomAD MAF ¼ 0.006,
being most frequent in non-Finnish Europeans (0.0097)
but rarest in East Asians (0.00005). Additionally, from
140 Minnesota families, of which 133 are European-
American, 7 European-American families were positive
for rs1800022, which was seen only in specific branches
or individuals (Figure S2), suggesting other susceptibility
variants per family.30 In 76 Colorado children, of which
56 are European-American, 1 European-American child is
heterozygous for rs1800022 (Table 2). The rs1800022
variant was also heterozygous in 2 out of 105 Finnish pro-
bands, but compared with gnomAD Finnish MAF this was
non-significant. On the other hand, when comparing theJournal of Human Genetics 103, 679–690, November 1, 2018 683
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Figure 2. Additional Microbiome Results in the IPOM and CU Cohorts
(A) Inter-individual variability in middle ear samples by cohort and FUT2 variant.
(B) Boxplots comparing biodiversity indices by cohort and FUT2 variant: richness measures the number of OTUs per sample (estimated
by Chao1), evenness measures the uniformity of OTU distributions (estimated by Shannon H/Hmax), while complexity (Shannon diver-
sity) combines both richness and evenness. Error bars indicate range of values; boxes show the first and third quartiles.gnomAD MAF of rs1800022 in non-Finnish Europeans
versus 21 heterozygous out of 358 affected European-
American children from Colorado, Texas, or Minnesota
(MAF ¼ 0.03), the variant was significantly associated
with otitis media (Fisher exact OR ¼ 3.1, 95%CI:1.9,4.8;
p ¼ 1.2 3 105). When we sequenced all DNA samples
from both parents of 333 children from Texas and Colo-
rado (Tables 1 and 2), 1 parent of each of the 14 children
with the rs1800022 variant also carry the variant, with 2
homozygous and 12 heterozygous parents. On the other
hand, in three trios the father carried the rs1800022
variant but the child was wild-type. Thus in US trios the
TDT for the rs1800022 variant was significant (p ¼ 0.02).
These findings support FUT2 c.412C>T (p.Arg138Cys) as
a novel rare variant conferring high risk for otitis media.
In the Texas trios, in agreement with the previously pub-
lished GWAS,2 several variants were in strong LD with stop
variant FUT2 c.461G>A (p.Trp154*; rs601338; Table 1),
including the GWAS locus, synonymous variant rs681343,
and missense variant c.772G>A (p.Gly258Ser; rs602662).
However, compared to gnomAD frequencies using Fisher
exact test, these variants were not significantly associated
with otitis media in Finnish probands. Additionally, in 140
multi-ethnic Minnesota families with otitis media, both684 The American Journal of Human Genetics 103, 679–690, Novemparametric and nonparametric linkage analyses using
rs602662genotypeshadnegative results. Sanger sequencing
of rs601338 in Minnesota and Pakistani families further
showed that thevariantdoesnot co-segregatewithotitisme-
dia (Figures S2 and S3). However, the rs601338 variant
was over-transmitted inTexas andColorado trios (180 trans-
mitted,127non-transmitted;TDTp¼0.002;Tables1and2),
implying that it is not protective against otitis media con-
trary topreviousGWASfindings.2 Furthermore,microbiome
analysis of middle ear samples from 13 individuals with
otitis media from Colorado demonstrated that carriage of
the rs601338 variant was associated with significant overall
shifts in middle ear microbiota composition (PERMANOVA
p<107) and increasedbiodiversity (Figure2).The rs601338
variant was also associated with increased relative abun-
dances of Enterobacteriaceae, Gammaproteobacteria, and Pro-
pionibacteriaceae and decreased relative abundance of
Pasteurellaceae (Figures 1B, 1C, and 2A); however, these
were only nominally significant due to small sample size
(FDR-adjusted p¼ 0.43). Taken together, these findings sug-
gest that the FUT2 c.461G>A (p.Trp154*) variant has a
potentially mild pathogenic effect on the middle ear micro-
biome and is probably overtaken by other stronger genetic
effects in familial otitis media.ber 1, 2018
Table 1. FUT2 Variants Identified in 257 Texan Children with Otitis Media
Ethnicity
CADD
Score White Hispanic Black Mixed/Other Transmitted
Non-
transmitted TDT p
N (total) 257 – 169 46 24 18 – – –
Variants AA Change
rs1800021 p.Ile25Val 0.001 1 1 2 1 4 7 0.37
rs681343a synonymous 3.2 118 (46 hom) 27 (3 hom) 20 (10 hom) 11 (3 hom) – – –
rs149356814 p.Ala104Val 23.4 1 0 0 0 1 0 0.32
rs200157007 p.Pro112Leu 24.5 0 0 0 2 2 0 0.16
rs1800022b p.Arg138Cys 28.5 13 0 0 0 11 2 0.01
rs1047781 p.Ile140Phe 23.5 0 0 0 2 1 0 0.32
rs601338a p.Trp154* 37.0 124 (47 hom) 26 (3 hom) 21 (10 hom) 11 (3 hom) 139 100 0.01
rs602662a p.Gly258Ser 23.6 122 (48 hom) 29 (5 hom) 22 (12 hom) 12 (4 hom) – – –
rs485186a synonymous 0.003 124 (48 hom) 29 (5 hom) 21 (13 hom) 12 (4 hom) – – –
All Variants 149c 102d 0.003
Variants with CADD > 20 only 150 105 0.005
CADD, Combined Annotation Dependent Depletion.
ars681343, rs601338, rs602662, and rs485186 are in strong LD.
brs1800022 is a risk variant for otitis media. Two carriers of this variant have chronic/effusive otitis media while the rest have recurrent acute otitis media. All nine
carriers required ventilation tube surgery by age 3 years (median 2 years). One child with chronic otitis media had multiple risk factors including family history of
otitis media, no breastfeeding, daycare attendance, additional small children in the household, and exposure to smoking. For two trios, a parent is homozygous for
the variant. In two additional trios, the father is heterozygous for rs1800022 but the child is wild-type.
cTotal transmitted variants were counted based on the sum of transmitted variants (total 158) minus the number of parent-child pairs with the same two hetero-
zygous variants (i.e., 5 pairs with both p.Arg138Cys and p.Trp154* and 1 pair with both p.Ile25Val and p.Trp154*) andminus 3 parent-child pairs where p.Ile25Val
is transmitted but p.Trp154*is non-transmitted.
dTotal non-transmitted variants were counted based on the sum of non-transmitted variants (total 109) minus the number of parents with two non-transmitted
heterozygous variants (i.e., 1 parent with both p.Arg138Cys and p.Trp154* non-transmitted and 3 parents with both p.Ile25Val and p.Trp154* non-transmitted)
and minus 3 parent-child pairs where p.Ile25Val is transmitted but p.Trp154*is non-transmitted.Three additional FUT2 variants were identified in
Texan children (Table 1): (1) c.311C>T (p.Ala104Val;
rs149356814) was predicted to be damaging (Mutation
Assessor, fathmm) and is heterozygous in one Euro-
pean-American child; (2) c.335C>T (p.Pro112Leu;
rs200157007) was predicted to be damaging (PolyPhen2,
MutationAssessor, fathmm) and is heterozygous in two
Asian-American children; and (3) c.418A>T (p.Ile140Phe;
rs1047781) was predicted to be damaging (PolyPhen2,
MutationAssessor, PROVEAN/SIFT, fathmm) but is anno-
tated in ClinVar as benign. The rs1047781 variant was
identified in two Asian-American children from Texas
(gnomAD East Asian MAF ¼ 0.47) but was not identified
in Minnesota, Finnish, or Pakistani families nor in Colo-
rado or Filipino simplex case subjects (all other gnomAD
MAF % 0.01). On the other hand, the two variants
rs149356814 and rs200157007 are rare in multiple
gnomAD populations but common in South Asians with
MAF of 0.02 and 0.13, respectively. When 19 Pakistani
families with otitis media were sequenced for these two
variants, rs200157007 was detected in four families but
does not co-segregate with otitis media. On the other
hand, in one consanguineous Pakistani family (PKOM11)
the low-frequency variant rs149356814 potentially co-seg-
regates with otitis media in one branch as an autosomal-
dominant trait, but it does not in family PKOM01
(Figure S3). Putting together the different FUT2 variantsThe Americanwith CADD score > 20 that were identified in Texan and
Coloradan trios, FUT2 is significantly associated with otitis
media risk (TDT p ¼ 0.001; Table 2).
As expected for fucosyltransferases, FUT2 protein local-
izes to the Golgi apparatus (Figure S4). In COS-7 cells trans-
fected with GFP constructs for FUT2 variants p.Ala104Val,
p.Arg138Cys, p.Trp154*, and p.Arg202*, FUT2 colocaliza-
tion to the Golgi apparatus is not affected (Figure S4). How-
ever, inmousemiddle ear during acute ntHI infection, Fut2
increases in expression 103, peaking at 24 hr, then returns
to normal by 5 days (Figure 3).
In order to determine cellular levels of FUT2 and A anti-
gen according to variant occurrence, flow cytometry
was performed using variant-transfected cells. Control
studies using IgM control antibody showed no significant
binding with or without variants (Figure S5). Flow cytom-
etry studies on GFP-FUT2 variant-transfected COS-7 cells
showed a significant decrease in FUT2 levels due to
nonsense variants p.Trp154* (n ¼ 8, p < 0.001) and
p.Trp202* (n ¼ 8, p % 0.001; Figures 4A and 4B). The
expression of p.Ala104Val and p.Arg138Cys variants was
not affected. These data were confirmed by western blot
analyses (Figure 4C).
Cell surface A blood group epitope levels on GFP-posi-
tive cells were analyzed for each variant (Figure 4D). A
antigen levels were observed in 42.5% of GFP-FUT2WT
cells compared to GFP-transfected cells (21.2%). TheJournal of Human Genetics 103, 679–690, November 1, 2018 685
Table 2. FUT2 Variants Identified in 76 Coloradan Children with Otitis Media
Ethnicity White Hispanic Black Mixed/Other Transmitted Non-transmitted TDT p
N (total) 76 56 6 0 14 – – –
Variants AA Change
rs1800022 p.Arg138Cys 1 0 0 0 1 1 1
rs601338 p.Trp154* 42 (15 hom) 5 (1 hom) 0 12 (4 hom) 41 27 0.09
Both variants 42 28 0.09
Combined with Texan trios (CADD > 20) 192 133 0.001accumulation of A antigen at the surface of cells trans-
fected with GFP-FUT2Ala104Val, GFP-FUT2Arg138Cys, GFP-
FUT2Trp154*, or GFP-FUT2Arg202* variant constructs was
significantly reduced (28.3%, 24%, 11.1%, and 13.2%,
respectively). Levels of B and H antigens could not be as-
sessed due to the lack of specific antibody for these anti-
gens. To summarize, Fut2 expression in wild-type mouse
middle ear with acute otitis media is transient, while at
the cellular level FUT2 variants affect A antigen levels if a
missense variant and both FUT2 and A antigen levels if a
nonsense variant.
We also examined a potential role of FUT2 in the devel-
opment of acquired cholesteatoma in themiddle ear due to
chronic otitis media. Cholesteatoma is a collection of squa-
mous debris encapsulated by keratinized epithelium that
develops in the middle ear, which is rarely congenital but
more commonly acquired after chronic otitis media and
can cause serious complications (e.g., intracranial spread,
hearing loss, facial nerve paralysis, vestibular loss) due to
erosion of surrounding temporal bone.31 FUT2 localization
was tested in human cholesteatoma matrix, but either
there was none or FUT2 was below the threshold level
for detection in cholesteatoma tissue (Figure S6). Interest-Figure 3. Fold Expression of Fut2 across Different Time Points
after Inoculation of Non-typeable Haemophilus influenzae into
the Mouse Middle Ear
Affymetrix probes 1434862_at (filled circles) and 1450246_at
(open circles), targeting Fut2 transcripts, revealed enhanced
expression that peaked at 24 hr post-infection. The 0 hr data point
represents uninfected middle ears. Vertical bars represent the
range of fold values observed for each probe on all arrays.
686 The American Journal of Human Genetics 103, 679–690, Novemingly, in our Filipino and Colorado cohorts, the carrier
frequencies of rs1800028 and rs601338 are increased in
individuals with cholesteatoma (Table S4). Differential
expression analysis of RNA-sequence data from saliva of
23 individuals with otitis media from Colorado according
to carriage of the rs601338 variant revealed only 3 genes
with FDR-adjusted p ¼ 0.07 (corresponding log-fold
changes as indicated): TRNV (10.9), TRNF (8.1), and
OSTM1 (3.9). Of these three genes, OSTM1 is connected
to a subnetwork of OM-related genes (Figure S7).Discussion
In this report we identified population-specific FUT2 vari-
ants conferring risk for otitis media susceptibility in multi-
ple cohorts of different ethnicity: (1) the c.604C>T
(p.Arg202*; rs1800028) variant that is common in South-
east Asians and co-segregates with otitis media in
A2ML1-negative Filipinos (Figure 1A); (2) the c.412C>T
(p.Arg138Cys; rs1800022) variant which is rare in popula-
tions of European ancestry but occurs at MAF ¼ 0.03 in
European-American children with otitis media, thus
increasing risk for otitis media by >33 (Tables 1 and 2);
(3) three additional missense variants in Texan or Pakistani
families (Table 1, Figure S3); and (4) the very common
c.461G>A (p.Trp154*; rs601338) variant which is signifi-
cantly associated with familial otitis media and induces
shifts in themiddle earmicrobiome (Tables 1 and 2, Figures
1B, 1C, and 2). All five variants combined are over-trans-
mitted inEuropean-American trioswithotitismedia (Tables
1 and 2). Moreover, both missense and nonsense variants
reduced A antigen expression in epithelial cells (Figure 4).
However, we did not find middle ear microbiome differ-
ences due to the p.Arg202* variant, which is possibly due
to the inclusion of indigenous individuals who also carry
A2ML1 variants that influence the middle ear micro-
biome32 (Figures 1B and 2). On the other hand, the
c.461G>A (p.Trp154*) variant influences richness and
complexity of themiddle earmicrobiome (Figure 2), which
is consistent with findings in the gastrointestinal tract
though predominant taxa in the gut may be different.33
The transient expression of Fut2 in the middle ear mu-
cosa during acute otitis media (Figure 3) implies that the
mechanism by which FUT2 variants affect middle earber 1, 2018
Figure 4. Flow Cytometry Profiles of GFP and Cell Surface A BloodGroup Epitope Levels by COS-7 Cells Transfectedwith HumanGFP-
FUT2 Variant Constructs
(A) COS-7 cells were transiently transfected for 72 hr with GFP-FUT2WT (green-filled traces) or GFP-FUT2 variant constructs (red traces).
GFP-positive (green traces) and non-transfected (gray traces) cells were used as negative controls. GFP-FUT2WT, GFP-FUT2Ala104Val, and
GFP-FUT2Arg138Cys transfected cells show the same GFP expression profiles while GFP-FUT2Trp154* and GFP-FUT2Arg202* transfected cells
show a decrease of GFP levels as compared to GFP-FUT2WT cells, meaning that those variants are less expressed or degraded quicker in
COS-7 cells.
(B) Quantification of the flow cytometry experiment shown in (A). ***p% 0.001; n.s.: non-significant. Error bars indicate5 SEM.
(C) Western blot analyses of COS-7 cells transfected with GFP-FUT2 variants. GFP and GAPDH blots are shown.
(D) COS-7 cells were transiently transfected for 72 hr with GFP, GFP-FUT2WT (green), or GFP-FUT2 variant constructs (red). Cell surface A
blood group epitope levels on GFP-positive cells were analyzed for each condition. 42.5% of GFP-FUT2WT cells have A antigen as
compared to GFP-transfected cells (21.2%). The accumulation of A antigen at the surface of cells transfected with GFP-FUT2Ala104Val,
GFP-FUT2Arg138Cys, GFP-FUT2Trp154*, or GFP-FUT2Arg202* variant constructs was significantly reduced (28.3%, 24%, 11.1%, and
13.2%, respectively).function mainly occurs during active infection. Because
FUT2 controls surface expression of A and B antigens and
their precursor H antigen in mucosal epithelia, we testedThe Americanlevels of these antigens in epithelial cells after variant
transfection. These experiments confirmed reduction of
A antigen levels due to both nonsense and missenseJournal of Human Genetics 103, 679–690, November 1, 2018 687
variants, as well as lower FUT2 levels due to nonsense var-
iants, the latter possibly due to protein degradation and/or
reduction of expression (Figure 4). These findings are
consistent with the function of A, B, or H antigens as pro-
teins used by bacteria for epithelial binding.34 A antigen in
particular is used by specific Lactobacilli strains in binding
to intestinal mucosa, while Escherichia coli strains that ex-
press A-specific adhesins infected only individuals with
blood group A.35,36 These are consistent with our own find-
ings of greater relative abundance of Lactobacillales and
Gammaproteobacteria in middle ears of FUT2 p.Trp154*
carriers (Figures 1B, 1C, and S8). Unfortunately, we have
middle ear microbiome data from only two individuals
who are homozygous for p.Trp154*, but these two individ-
uals have higher relative abundance of Streptococcaceae
(Figure S8). Interestingly, virulent strains of Streptococcus
pneumoniae, a common cause of acute otitis media, use
the type I operon to primarily target Lewis antigen which
is regulated not only by FUT2 but also by FUT3 (MIM:
111100);37,38 this may imply that nonsecretor status due
to homozygosity for FUT2 p.Trp154* might decrease infec-
tion by other bacteria but increases predisposition to
Streptococcal infection. In addition to affecting bacterial
adherence, FUT2 nonsecretor status has been shown to
lead to significantly greater lymphocyte infiltration during
infection.39 Taken together these findings suggest that
each FUT2 genotype may predispose to specific bacterial
infections and might also be the reason for the apparent
contradiction to previous GWAS findings, such that the
heterozygous genotype confers susceptibility to bacteria
that are known for chronic otitis media and therefore
repeated childhood ear infections, while the homozygous
genotype may cause acute otitis media e.g., Streptococcal,
albeit recurrent.
Within the indigenous Filipino population, an elderly
female who is heterozygous for FUT2 p.Arg202* was the
only person diagnosed with cholesteatoma (Figure 1A).
Although numbers of individuals with cholesteatoma are
small, we observed an increased prevalence of FUT2 het-
erozygous genotypes in those with cholesteatoma due to
chronic infection (Table S4). In individuals who carry the
FUT2 p.Trp154* variant, there is lower expression of
OSTM1 (MIM: 607649). In humans, OSTM1 mutations
cause autosomal-recessive, rare, severe osteopetrosis
(MIM: 259720), a condition characterized by reduced oste-
oclast number and activity, bony sclerosis, fractures,
reduced bone marrow cavities, pancytopenia, recurrent in-
fections, and early death,40 consistent with hematopoietic
and osteoclast defects in gl/Ostm1-mutant mice.41 Since we
identified individuals with FUT2 stop variants with choles-
teatomas and/or downregulated OSTM1 expression,
reduced FUT2 levels might play a role in cholesteatoma for-
mation and bone pathology in part via decreased OSTM1
levels.
In summary, we identified FUT2 variants conferring
risk for otitis media in a multi-ethnic cohort of well-
phenotyped families. FUT2 belongs to a select group of688 The American Journal of Human Genetics 103, 679–690, Novemgenes (e.g., CFH for age-related macular degeneration,42
CARD14 for psoriasis43) documented to have variants
with a wide range of MAF and effect sizes in the same direc-
tion. The frequency of population-specific FUT2 variants
makes this gene a potential target for preventive screening
and future treatments for otitis media, including modula-
tion of the middle ear microbiome. Though FUT2 upregu-
lation during acute infection is transient, it is likely that
the risk variants ultimately predispose to recurrent or
chronic otitis media (Figure 1A; Tables 1, 2, S2, and S3).
Our families demonstrate marked intra-familial genetic
heterogeneity, suggesting that multiple combinations of
common and rare variants plus environmental factors
influence the individual otitis media phenotype as a com-
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